Prevalence of hepatitis B, D and C virus infections among children and pregnant women in Moldova: Additional evidence supporting the need for routine hepatitis B vaccination of infants

Epidemiology and Infection

Volumn 123, Issue 3, 1999, Pages 463-467

  Drobeniuc, J ^a   Hutin, Y J F ^b,e   Harpaz, R ^c   Favorov, M ^b   Melnik, A ^a   Iarovoi, P ^a   Shapiro, C N ^b   Woodruff, B A ^d  

^a Natl Ctr Sci Appl Hyg E   (Moldova)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTERS FOR DIS CONTR AND PREV   (United States)

^d NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIGEN; HEPATITIS DELTA ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; DELTA AGENT HEPATITIS; DISEASE CONTROL; ENDEMIC DISEASE; FEMALE; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; MALE; MOLDOVA; NEWBORN; NORMAL HUMAN; PERINATAL INFECTION; PREGNANCY; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; VACCINATION;

ADULT; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS D; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOLDOVA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; VIRAL HEPATITIS VACCINES;

EID: 0033386605     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268899003003     Document Type: Article

References (23)

1. McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151: 599-603.
2. Kostritsa SS, Kusin SN, Khukhlowitch PA, Shakhgildian IV, Dorsheno NV, Blinov VM. The frequency of antibody to hepatitis C virus and HBsAg detection in blood donors, patients with viral hepatitides and oncological diseases in Moldova Republic. Vopr Virusol 1994; 39: 93-4.
3. Drobeniuk ZA, Mikhailov MI, Bokancha GV, Iarovoi PI, Anan'ev VA, Shakhgil'dian IV. The frequency of detection of HBsAg, anti-HBs and anti-HBc in the healthy population of the Moldovan SSR. Vopr Virusol 1988; 33: 621-4.
4. Bennett S, Woods T, Liyanage WM, Smith DL. A simplified general method for cluster-sample surveys of health in developing countries. World Health Stat Q 1991; 44: 98-106.
5. Dean AG, Dean JA, Coulombier D, et al. Epi Info, Version 6: A word-processing, database, and statistics program for public health on IBM-compatible microcomputers. Atlanta, Georgia, USA; Centers for Disease Control and Prevention, 1994.
6. Maynard JE, Kane MA, Hadler SC. Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization. Rev Infect Dis 1989; 11 (Suppl 3): S574-8.
7. Beasley RP, Trepo C, Stevens CE, Szmuness, W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1997; 105; 94-8.
8. Davis LG, Weber DJ, Lemon SM. Horizontal transmission of hepatitis B virus. Lancet 1989; i: 889-93.
9. Whittle HC, Bradley AK, McLauchlan K, Ajdukiewicz AB, Howard CR, Zuckerman AJ. Hepatitis B virus infection in two Gambian villages. Lancet 1983; i: 1203-6.
10. Petersen NJ, Barrett DH, Bond WW, Berquist KR, Favero MS, Bender TR. Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages. Appl Environ Microbiol 1976; 32: 572-4.
11. Vall Mayans M, Hall AJ, Inskip HM, Chotard J, Lindsay SW, Coromina E. Risk factors for transmission of hepatitis B virus to Gambian children. Lancet 1990; 336: 1107-9.
12. Martison FEA, Weigle KA, Royce RA, Weber DJ, Suchindran CM, Lemon SM. Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. Am J Epidemiol 1998; 147: 478-87.
13. Hutin YJF, Harpaz R, Drobeniuc J, et al. Injections given in health care settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol 1999; 28: 782-6.
14. Coursaget P, Yvonnet B, Chotard J, Vincelot P, Sarr M, Diouf C. Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol 1987; 22: 1-5.
15. Beasley RP, Hwang LY, Lin CC, Leu ML, Stevens CE, Szmuness W. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 1982; 146: 198-204.
16. Paquet C, Babes VT, Drucker J, Senemaud B, Dobrescu A. Viral hepatitis in Bucharest. Bull WHO 1993; 71: 781-6.
17. Woodruff BA, Popovici F, Beldescu N, Shapiro CN, Hersh BS. Hepatitis B virus infection among pregnant women in northeastern Romania. Int J Epidemiol 1993; 22: 923-6.
18. Polish LB, Gallagher M, Fields HA, Hadler SC. Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microbiol Rev 1993; 6: 211-29.
19. Alter MJ. Epidemiology and disease burden of hepatitis B and C. Antiviral Ther 1996; 1 (suppl. 3): 9-14.
20. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995; 15: 5-14.
21. Poovorawan Y, Sanpavat S, Pongpunlert W, Chumderpadetsuk S, Sentrakul P, Safary A. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA 1989; 261: 3278-81.
22. Hall AJ, Roberston RL, Crivelli PE, Lowe Y, Inskip H, Snow SK. Cost-effectiveness of hepatitis B vaccine in The Gambia. Trans R Soc Trop Med Hyg 1993; 87: 333-6.
23. Centers for Disease Control and Prevention. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991; 40 (RR-13).